PEGylation of a proprotein convertase peptide inhibitor for vaginal route of drug delivery: In vitro bioactivity, stability and in vivo pharmacokinetics

Peptides - Tập 38 - Trang 266-274 - 2012
Huiting Ho1,2, Tracy L. Nero3, Harmeet Singh1, Michael W. Parker3,4, Guiying Nie1
1Prince Henry's Institute of Medical Research, Clayton, Victoria 3168, Australia
2Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3168, Australia
3Biota Structural Biology Laboratory, St. Vincent's Institute of Medical Research, Fitzroy, Victoria 3065, Australia
4Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, 30 Flemington Road, Parkville, Victoria 3010, Australia

Tài liệu tham khảo

Anderson, 1993, Inhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed alpha 1-antitrypsin variant, J Biol Chem, 268, 24887, 10.1016/S0021-9258(19)74548-7 Bulletti, 2001, Uterine contractility: vaginal administration of the beta-adrenergic agonist, terbutaline. Evidence of direct vagina-to-uterus transport, Ann N Y Acad Sci, 943, 163, 10.1111/j.1749-6632.2001.tb03800.x Cicinelli, 1998, Plasma concentrations of progesterone are higher in the uterine artery than in the radial artery after vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women, Fertil Steril, 69, 471, 10.1016/S0015-0282(97)00545-1 Cicinelli, 1999, Transvaginal progesterone: evidence for a new functional ‘portal system’ flowing from the vagina to the uterus, Hum Reprod Update, 5, 365, 10.1093/humupd/5.4.365 Cicinelli, 2000, Direct transport of progesterone from vagina to uterus, Obstet Gynecol, 95, 403, 10.1016/S0029-7844(99)00542-6 Cicinelli, 2004, Preferential transfer of endogenous ovarian steroid hormones to the uterus during both the follicular and luteal phases, Hum Reprod, 19, 2001, 10.1093/humrep/deh404 Cu, 2011, In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery, J Control Release, 156, 258, 10.1016/j.jconrel.2011.06.036 De Ziegler, 1997, The first uterine pass effect, Ann N Y Acad Sci, 828, 291, 10.1111/j.1749-6632.1997.tb48550.x Decroly, 1996, Identification of the paired basic convertases implicated in HIV gp160 processing based on in vitro assays and expression in CD4(+) cell lines, J Biol Chem, 271, 30442, 10.1074/jbc.271.48.30442 Dimitriadis, 2002, Interleukin 11 advances progesterone-induced decidualization of human endometrial stromal cells, Mol Hum Reprod, 8, 636, 10.1093/molehr/8.7.636 Edgar, 2004, MUSCLE: a multiple sequence alignment method with reduced time and space complexity, BMC Bioinformatics, 5, 113, 10.1186/1471-2105-5-113 Edgar, 2004, MUSCLE: multiple sequence alignment with high accuracy and high throughput, Nucleic Acids Res, 32, 1792, 10.1093/nar/gkh340 Evron, 2011, Effect of primary human endometrial stromal cells on epithelial cell receptivity and protein expression is dependent on menstrual cycle stage, Hum Reprod, 26, 176, 10.1093/humrep/deq296 Ficicioglu, 2004, High local endometrial effect of vaginal progesterone gel, Gynecol Endocrinol, 18, 240, 10.1080/09513590410001692519 Freyer, 2007, Pro-protein convertases (PCs) other than PC6 are not tightly regulated for implantation in the human endometrium, Reproduction, 133, 1189, 10.1530/REP-06-0285 Fugere, 2007, Short polybasic peptide sequences are potent inhibitors of PC5/6 and PC7: use of positional scanning-synthetic peptide combinatorial libraries as a tool for the optimization of inhibitory sequences, Mol Pharmacol, 71, 323, 10.1124/mol.106.027946 Fugere, 2005, Cutting back on pro-protein convertases: the latest approaches to pharmacological inhibition, Trends Pharmacol Sci, 26, 294, 10.1016/j.tips.2005.04.006 Gellersen, 2007, Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives, Semin Reprod Med, 25, 445, 10.1055/s-2007-991042 Hallenberger, 1992, Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160, Nature, 360, 358, 10.1038/360358a0 Heng, 2010, Posttranslational activation of bone morphogenetic protein 2 is mediated by proprotein convertase 6 during decidualization for pregnancy establishment, Endocrinology, 151, 3909, 10.1210/en.2010-0326 Henrich, 2003, The crystal structure of the proprotein processing proteinase furin explains its stringent specificity, Nat Struct Biol, 10, 520, 10.1038/nsb941 Huang, 2000, Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces, J Control Release, 65, 63, 10.1016/S0168-3659(99)00233-3 Jain, 2007, Surflex-Dock 2.1: robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search, J Comput Aided Mol Des, 21, 281, 10.1007/s10822-007-9114-2 Kibler, 2004, Polyarginine inhibits gp160 processing by furin and suppresses productive human immunodeficiency virus type 1 infection, J Biol Chem, 279, 49055, 10.1074/jbc.M403394200 Laskowski, 1993, Procheck – a program to check the stereochemical quality of protein structures, J Appl Crystallogr, 26, 283, 10.1107/S0021889892009944 Luthy, 1992, Assessment of protein models with three-dimensional profiles, Nature, 356, 83, 10.1038/356083a0 Miles, 1994, Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study, Fertil Steril, 62, 485, 10.1016/S0015-0282(16)56935-0 Miranda, 1996, Isolation of the human PC6 gene encoding the putative host protease for HIV-1 gp160 processing in CD4+ T lymphocytes, Proc Natl Acad Sci U S A, 93, 7695, 10.1073/pnas.93.15.7695 Nie, 2005, Inhibiting uterine PC6 blocks embryo implantation: an obligatory role for a proprotein convertase in fertility, Biol Reprod, 72, 1029, 10.1095/biolreprod.104.036889 Nie, 2003, Specific and transient up-regulation of proprotein convertase 6 at the site of embryo implantation and identification of a unique transcript in mouse uterus during early pregnancy, Biol Reprod, 68, 439, 10.1095/biolreprod.102.006676 Okada, 2005, Requirement for proprotein convertase 5/6 during decidualization of human endometrial stromal cells in vitro, J Clin Endocrinol Metab, 90, 1028, 10.1210/jc.2004-0904 Okada, 1984, Vaginal absorption of a potent luteinizing hormone-releasing hormone analogue (leuprolide) in rats IV: evaluation of the vaginal absorption and gonadotropin responses by radioimmunoassay, J Pharm Sci, 73, 298, 10.1002/jps.2600730304 Pasut, 2004, Protein, peptide and non-peptide drug PEGylation for therapeutic application, Expert Opin Ther Pat, 14, 859, 10.1517/13543776.14.6.859 Powell, 1993, Peptide stability in drug development II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serum, Pharm Res, 10, 1268, 10.1023/A:1018953309913 Radomsky, 1992, Controlled vaginal delivery of antibodies in the mouse, Biol Reprod, 47, 133, 10.1095/biolreprod47.1.133 Reissmann, 2000, The LHRH antagonist cetrorelix: a review, Hum Reprod Update, 6, 322, 10.1093/humupd/6.4.322 Salamonsen, 2003, Complex regulation of decidualization: a role for cytokines and proteases – a review, Placenta, 24, S76, 10.1053/plac.2002.0928 Salamonsen, 2009, Society for Reproductive Biology Founders’ Lecture 2009. Preparing fertile soil: the importance of endometrial receptivity, Reprod Fertil Dev, 21, 923, 10.1071/RD09145 Sayani, 1996, Systemic delivery of peptides and proteins across absorptive mucosae, Crit Rev Ther Drug Carrier Syst, 13, 85 Schick, 1943, Changes in the whole vagina of the mouse during estrus and pregnancy, J Morphol, 72, 305, 10.1002/jmor.1050720207 Seidah, 1998, Precursor convertases: an evolutionary ancient, cell-specific, combinatorial mechanism yielding diverse bioactive peptides and proteins, Ann N Y Acad Sci, 839, 9, 10.1111/j.1749-6632.1998.tb10727.x Shiryaev, 2007, Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens, J Biol Chem, 282, 20847, 10.1074/jbc.M703847200 Singh, 2011, Decidual HtrA3 negatively regulates trophoblast invasion during human placentation, Hum Reprod, 26, 748, 10.1093/humrep/der019 Taylor, 2003, Curbing activation: proprotein convertases in homeostasis and pathology, FASEB J, 17, 1215, 10.1096/fj.02-0831rev Veronese, 2005, PEGylation, successful approach to drug delivery, Drug Discov Today, 10, 1451, 10.1016/S1359-6446(05)03575-0 Vollenweider, 1996, Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertases, Biochem J, 314, 521, 10.1042/bj3140521 Werle, 2006, Strategies to improve plasma half life time of peptide and protein drugs, Amino Acids, 30, 351, 10.1007/s00726-005-0289-3 White, 2007, Blocking LIF action in the uterus by using a PEGylated antagonist prevents implantation: a nonhormonal contraceptive strategy, Proc Natl Acad Sci U S A, 104, 19357, 10.1073/pnas.0710110104 Woodley, 2001, Bioadhesion: new possibilities for drug administration, Clin Pharmacokinet, 40, 77, 10.2165/00003088-200140020-00001 Zheng, 2007, Native PAGE eliminates the problem of PEG-SDS interaction in SDS-PAGE and provides an alternative to HPLC in characterization of protein PEGylation, Electrophoresis, 28, 2801, 10.1002/elps.200600807